Susquehanna International Group
ONCE

Susquehanna International Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Susquehanna International Group’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-29,421
Closed -$2.85M – 11169
2019
Q3 		$2.85M Hold
29,421
– – ﹤0.01% 3577
2019
Q2 		$3.01M Buy
29,421
+12,094
+70% +$1.31M ﹤0.01% 3441
2019
Q1 		$1.97M Sell
17,327
-2,794
-14% -$205K ﹤0.01% 3764
2018
Q4 		$788K Sell
20,121
-9,300
-32% -$403K ﹤0.01% 5144
2018
Q3 		$1.6M Hold
29,421
– – ﹤0.01% 4354
2018
Q2 		$2.44M Hold
29,421
– – ﹤0.01% 3692
2018
Q1 		$1.96M Hold
29,421
– – ﹤0.01% 3953
2017
Q4 		$1.51M Buy
29,421
+50
+0.2% +$3.59K ﹤0.01% 4450
2017
Q3 		$2.62M Hold
29,371
– – ﹤0.01% 3440
2017
Q2 		$1.75M Sell
29,371
-205
-0.7% -$11.5K ﹤0.01% 4153
2017
Q1 		$1.58M Hold
29,576
– – ﹤0.01% 4167
2016
Q4 		$1.48M Hold
29,576
– – ﹤0.01% 4705
2016
Q3 		$1.78M Sell
29,576
-41
-0.1% -$2.36K ﹤0.01% 3757
2016
Q2 		$1.51M Sell
29,617
-33,854
-53% -$1.45M ﹤0.01% 4071
2016
Q1 		$1.87M Buy
63,471
+16,127
+34% +$509K ﹤0.01% 3904
2015
Q4 		$2.15M Sell
47,344
-28,082
-37% -$1.47M ﹤0.01% 3896
2015
Q3 		$3.15M Buy
75,426
+36,408
+93% +$1.9M ﹤0.01% 3411
2015
Q2 		$2.35M Buy
39,018
+35,150
+909% +$2.32M ﹤0.01% 4368
2015
Q1 		$300K Buy
+3,868
New +$223K ﹤0.01% 7981

Susquehanna International Group's ONCE Position: Q4 2019 in Review

Susquehanna International Group sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 29,421 shares — an estimated $2.85M sold.

Susquehanna International Group first reported a position in ONCE in Q1 2015 and held it in 19 quarters. The position peaked at $3.15M in Q3 2015. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Susquehanna International Group reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Susquehanna International Group sold 29,421 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2.85M.
  • Susquehanna International Group first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 19 quarters.
  • Susquehanna International Group's Spark Therapeutics, Inc. Common Stock position peaked at $3.15M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.